Novo Nordisk has launched an oral Wegovy pill in the U.S., offering a lower-cost alternative to injections and intensifying ...

Novo Nordisk has launched the first once-daily oral version of Wegovy, marking the arrival of the first GLP-1 weight-loss ...

The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

Novo Nordisk is the first manufacturer to market its drug Wegovy in pill form in the U.S., though Eli Lilly expects approval ...

FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo ...

The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve ...

Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...

Now the arrival of a Wegovy pill in U.S. pharmacies feels like a line in the sand between the first and second era of ...

The FDA-approved weight loss drug offers an oral alternative to invasive injections with similar effectiveness.

The new oral drug costs as little as $149 a month out of pocket and is expected to broaden access as demand for GLP-1 ...

The monthly out-of-pocket cost is less than the $349 price for monthly injections, but the savings vary by dose.

Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game.